Coursera Spring Sale
40% Off Coursera Plus Annual!
Grab it
Explore the critical role of clinical laboratories in diagnosing cardiovascular diseases through this comprehensive webinar presented by Dr. Jieli (Shirley) Li, MD, PhD, Associate Professor-Clinical in the Department of Pathology and Co-Director of the Clinical Chemistry & Toxicology Laboratory. Delve into the complex interplay of systems involved in cardiometabolic syndrome, a condition affecting approximately 25% of adults worldwide and characterized by insulin resistance, impaired glucose metabolism, dyslipidemia, and hypertension. Understand how metabolic dysfunction can lead to cardiac remodeling, coronary heart disease, and heart failure, while examining the increasing incidence of cardiometabolic syndrome alongside rising rates of obesity, diabetes, and hypertension. Learn about current scientific research focused on addressing diverse risk factors and identifying new diagnostic biomarkers through an integrated approach for treating these conditions across various populations. Discover the pathophysiology and risk assessment strategies for precision health, including molecular and metabolic biomarkers of metabolic cardiovascular disease, with special emphasis on posttranslational modification of troponin. Gain insights from Dr. Li's extensive expertise, including her fellowship training in clinical chemistry at MD Anderson Cancer Center, her authorship of over 40 scientific articles, and her active involvement with professional organizations including the Clinical & Laboratory Standards Institute (CLSI), College of American Pathologists (CAP), and Association for Diagnostics & Laboratory Medicine (ADLM). Earn PACE credits by completing the webinar and following the provided certification process, with credits valid until November 13, 2026.
